Abstract
For the management of bladder cancer, 2018 has been characterized by deepened knowledge on the molecular basis of invasive bladder cancer and its potential interaction with existing therapies, optimization of the use of immune checkpoint inhibitors, and emerging early signals on new therapeutic classes for advanced disease.
Cite
CITATION STYLE
APA
Teo, M. Y., & Rosenberg, J. E. (2019, February 1). Refining existing knowledge and management of bladder cancer. Nature Reviews Urology. Nature Publishing Group. https://doi.org/10.1038/s41585-018-0137-3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free